Patient Assistance Program
ClearNote Health Cares - Patient Assistance Program
ClearNote Health welcomes all insurance plans. Your level of coverage varies by plan type. We offer financial assistance to qualifying patients who are uninsured or underinsured. To learn more about eligibility, please reach out to the ClearNote Health Customer Success Team.
Frequently Asked Questions
Yes, you may be eligible to participate in our Financial Assistance Program if you do not have insurance. A Good Faith Estimate noting your estimated financial responsibility can be requested if it is not provided automatically. Eligibility is based on income criteria set forth by the Department of Health and Human Services and ClearNote Health. Depending on your annual income you may be eligible for no-cost share or a reduced-cost share. Please contact our Billing and Reimbursement Department for more details.
Yes, you may be eligible if you have commercial insurance coverage. Eligibility is income-dependent and determined based on your insurance coverage determination. A Good Faith Estimate noting your estimated financial responsibility can be requested.
Yes, Medicare members and Medicaid members are able to participate.
You may be eligible to pre-qualify for financial assistance, depending on your economic situation. For more information on the eligibility criteria, please contact the ClearNote Health Reimbursement Team at:
866-414-0070 Mon-Fri 8a-7p EST / 5a-4p PST
No, you must apply for the program to qualify. The ClearNote Health Reimbursement Team will determine if you meet the eligibility criteria.
No, ClearNote Health does not charge a fee to apply for the program.
You may receive an EOB from your insurance company after your Avantect Cancer Test. If you are concerned or would like to understand about your patient’s responsibility, please contact the ClearNote Health Reimbursement Team at:
866-414-0070 Mon–Fri, 8a–7p EST / 5a–4p PST
Please contact the ClearNote Health Reimbursement Team. We may assist you through the claims process with your insurance company.
If you receive a denial from your insurance company, please contact our Billing and Reimbursement Department to give ClearNote Health permission to appeal the claims denial on your behalf.
DOWNLOAD CLEARNOTE HEALTH’S PATIENT FINANCIAL ASSISTANCE PROGRAM FAQs
For more information on billing and reimbursement or to apply for financial assistance, call us at
+1 866-414-0070, Mon-Fri, 8am-7pm EST / 5am-4pm PST
Important information
The Avantect Pancreatic Cancer Test is an early detection test. The test does not establish a diagnosis of pancreatic cancer, and results should be considered in the context of other clinical criteria. Definitive diagnosis of pancreatic cancer usually requires a series of imaging scans, blood tests, and a biopsy. Not all pancreatic cancers will be detected. Some patients with pancreatic cancer may have a “Signal not detected” result. Some patients without pancreatic cancer may have a “Signal detected” result. False-negative and false-positive results are possible. A “Signal not detected” result does not guarantee that no pancreatic cancer is present. In some cases, no result is obtained. While this is very uncommon, it may be caused by shipping delays or when there is not enough cell-free DNA for the test in the patient’s blood. If this happens, we generally ask for a repeat blood sample for testing at no extra cost.
The test was developed in the ClearNote Health CLIA-certified (CLIA# 05D2249973) and CAP-accredited (CAP# 9219174) laboratory and has not been cleared or approved by the US Food and Drug Administration (FDA).
References and notes
- ClearNote Health, data on file.